Valneva SE VALN
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -38.21%
- 1 year
- -40.31%
- Open
- 5.61
- Prev close
- 5.71
- Mkt cap
- 516.79M
- Vol
- 7.93K
- Avg vol
- 76.95K
- EPS
- -2.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.41
- High
- 5.61
- Forward P/E
- -7.21
- Beta
- 1.02
- Short ratio
- 1.22
- Inst. own
- 1.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.88
- 200-d avg
- 6.81
- 1y target
- 15.85
News
2 weeks ago globenewswire.com
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Lyon (France), October 14, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in meetings with…
2 weeks ago benzinga.com
Full Transcript: Valneva Q2 2026 Earnings Call
Valneva (NASDAQ:VALN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For…
3 weeks ago benzinga.com
UK Revokes Approval for Valneva's Chikungunya Shot
UK MHRA revokes Valneva’s IXCHIQ chikungunya vaccine authorization over traveler benefit-risk review. Minimal financial impact expected.
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million. Profound Medical (NASDAQ:PROF) stock rose 16.98%…
3 weeks ago globenewswire.com
Valneva Provides Update on IXCHIQ® in the United Kingdom
Lyon (France), October 07, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ® for…
1 month ago defenseworld.net
Analyzing Valneva (NASDAQ:VALN) and Septerna (NASDAQ:SEPN)
Valneva (NASDAQ: VALN - Get Free Report) and Septerna (NASDAQ: SEPN - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based…
1 month ago defenseworld.net
Contrasting Absci (NASDAQ:ABSI) & Valneva (NASDAQ:VALN)
Valneva (NASDAQ: VALN - Get Free Report) and Absci (NASDAQ: ABSI - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based…
2 months ago benzinga.com
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.
2 months ago benzinga.com
Applied Optoelectronics, SanDisk, Seagate And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Stock futures mixed, Nasdaq 100 down 100 points. Applied Optoelectronics falls after announcing $600M offering. Other pre-market losers include RFAI, ZSTK, ZKH, JMIA, VALN, MFI, COHR, SNDK, AXTI,…
2 months ago seekingalpha.com
Valneva: The Lyme Royalty Transition Changes The Earnings Model
Valneva (VALN) is transitioning from a low-margin vaccine manufacturer to a high-margin royalty and milestone model, anchored by its Lyme disease partnership with Pfizer. Recent financials were…
2 months ago benzinga.com
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
Valneva SE (NASDAQ:VALN) stock is surging on Friday after the company and its partner Pfizer Inc. (NYSE:PFE) announced that the European Medicines Agency (EMA) has validated the Marketing…
2 months ago benzinga.com
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed with Pfizer (PFE). Phase 3 trial showed efficacy and no safety concerns, pending regulatory approval.
2 months ago benzinga.com
Dow Falls Over 100 Points; US Consumer Sentiment Declines In August
Dow falls 0.26% while Nasdaq drops 0.51%. Energy shares rise 1.3%, tech stocks fall 0.6%. US retail sales down 0.6%, consumer sentiment declines.
2 months ago benzinga.com
Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday
U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report…
2 months ago benzinga.com
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
2 months ago businesswire.com
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
NEW YORK & LYON, France--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the…
2 months ago globenewswire.com
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
NEW YORK & LYON, France, August, 14, 2026 Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the…
2 months ago seekingalpha.com
Valneva SE (VALN) Q2 2026 Earnings Call Transcript
Valneva SE (VALN) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
Valneva Q2 Earnings Call Highlights
Valneva NASDAQ: VALN reported lower first-half revenue and wider losses for 2026, while maintaining its full-year sales outlook and emphasizing its cash position, restructuring measures and…
-
2 months ago benzinga.com
Conference Call: Valneva Affirms FY2026 Sales Guidance of $169.795M-$187.360M vs $171.630M Est
Valneva (NASDAQ:VALN) affirms FY2026 sales outlook from $169.795 million-$187.360 million to $169.795 million-$187.360 million vs $171.630 million estimate.
-
2 months ago benzinga.com
Valneva Reports H1 2026 Product Sales Of €64.0M Down From €91.0M YoY, Net Loss Widens To €63.3M From €20.8M YoY
Total product sales of €64.0 millionIn-line with expectations; full-year guidance of €135 -150 million reaffirmedSolid cash position of €121.5 million as of end June 2026Reflects disciplined cash…
2 months ago globenewswire.com
Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates
Lyon (France), August 13, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its condensed consolidated financial results for the first half of the…
2 months ago globenewswire.com
Valneva publie ses résultats financiers du premier semestre 2026 et fait un point sur ses activités
Ventes totales de produits de 64,0 millions d'euros o En ligne avec les attentes; confirmation de la prévision annuelle de ventes comprises entre 135 et 150 millions d'euros. Solide position de…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global…
3 months ago globenewswire.com
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
Lyon (France), July 22, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first half 2026 financial results on Thursday,…
4 months ago seekingalpha.com
Valneva SE (VALN) Shareholder/Analyst Call Prepared Remarks Transcript
Valneva SE (VALN) Shareholder/Analyst Call Prepared Remarks Transcript
4 months ago globenewswire.com
Valneva Announces Successful Outcome of its Annual General Meeting
Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that…
5 months ago globenewswire.com
Valneva Announces Availability of Documentation for its Annual General Meeting
Lyon (France), June 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Annual General…
5 months ago globenewswire.com
Valneva to Participate at U.S. and European Investor Conferences in June
Lyon (France), May 28, 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at…
5 months ago globenewswire.com
Valneva annonce sa participation à des conférences investisseurs aux États-Unis et en Europe
Lyon (France), le 28 mai 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que des membres de son équipe dirigeante participeront, en…
5 months ago marketbeat.com
Valneva Q1 Earnings Call Highlights
Valneva NASDAQ: VALN reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on conserving cash as it awaits the next regulatory steps for its…
-
5 months ago benzinga.com
Transcript: Valneva Q1 2026 Earnings Conference Call
Transcript: Valneva Q1 2026 Earnings Conference Call
-
5 months ago benzinga.com
Valneva Lowers FY2026 Sales Guidance from $180.443M-$197.906M to $169.795M-$187.360M vs $192.800M Est
Valneva (NASDAQ:VALN) lowers FY2026 sales outlook from $180.443 million-$197.906 million to $169.795 million-$187.360 million vs $192.800 million estimate.
-
5 months ago benzinga.com
Valneva Q1 EPS $(0.42) Misses $(0.21) Estimate, Sales $36.189M Miss $46.270M Estimate
Valneva (NASDAQ:VALN) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.21) by 100 percent. This is a 223.08 percent decrease over losses of $(0.13)…
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
6 months ago benzinga.com
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 results, cuts FY guidance. Other stocks also down.
6 months ago benzinga.com
Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Dow futures up 250 points. Sonoco Products Co (SON) shares down 5.7% in pre-market after reporting lower-than-expected earnings and sales.
6 months ago benzinga.com
Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
7 months ago benzinga.com
Crude Oil Falls Sharply; Dell Shares Spike Higher
Dow up 2.45%, Nasdaq up 2.46%, S&P 500 up 2.19%. Consumer discretionary shares up 3.6%, energy stocks up 0.3%. Dell announces enhancements, BofA raises price target. Apogee up 17%, Tower Semi up 9%,…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
7 months ago benzinga.com
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
Valneva stock drops after Phase 3 Lyme vaccine misses primary endpoint; secondary data shows efficacy as Pfizer backs regulatory submissions.
7 months ago benzinga.com
Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February
Dow Jones rises over 800 points on Monday as U.S. stocks trade higher. NASDAQ and S&P 500 also see gains. Consumer discretionary shares climb, construction spending falls.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
7 months ago benzinga.com
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 results for Lyme disease vaccine. Other stocks also down.
-
7 months ago benzinga.com
Pfizer, Valneva Report Topline Results From Phase 3 VALOR Clinical Trial Of Investigational 6-Valent OspA-Based Lyme Disease Vaccine Candidate PF-0730740; Trial Shows More Than 70% Efficacy In Preventing Lyme Disease In Individuals Aged Five Years And Above
Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and aboveThe investigational vaccine candidate was well tolerated…
-
7 months ago benzinga.com
Elaris Secures Global License From Valneva For C. difficile Vaccine Tech, Targets Clinical Trials By 2027
Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive global license agreement with Valneva SE…
7 months ago benzinga.com
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Dow futures up 200 points, ClearPoint Neuro (CLPT) stock falls after wider-than-expected quarterly loss. Other stocks moving lower in pre-market.